DUPILUMAB

DUPILUMAB was reported 518489 times

DUPILUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND ATOPIC DERMATITIS 2002 0.9965
1 REBOUND ECZEMA 2020 0.9858
2 DERMATITIS ATOPIC 48270 0.9145
3 EOSINOPHILIC OESOPHAGITIS 2025 0.7305
4 NEURODERMATITIS 2593 0.6959
5 ECZEMA INFANTILE 65 0.6771
6 EXPOSURE VIA SKIN CONTACT 16495 0.6359
7 PERIORBITAL IRRITATION 215 0.6287
8 SKIN WEEPING 2192 0.6138
9 ECZEMA EYELIDS 319 0.5696
10 EYELID SKIN DRYNESS 688 0.5672
11 ECZEMA 28786 0.5495
12 NASAL POLYPECTOMY 81 0.5094
13 PERIORBITAL INFLAMMATION 112 0.4848
14 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 69 0.4662
15 INJECTION SITE DRYNESS 414 0.4575
16 MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION 111 0.4568
17 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7754 0.4561
18 NASAL POLYPS 2228 0.4520
19 INJECTION SITE ECZEMA 84 0.4375
20 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 255 0.4236
21 SKIN FISSURES 7949 0.4063
22 HAND DERMATITIS 280 0.4040
23 INJECTION SITE EXFOLIATION 268 0.4018
24 EYELID RASH 391 0.3998
25 OESOPHAGEAL FOOD IMPACTION 211 0.3788
26 PRODUCT DOSE OMISSION IN ERROR 10694 0.3773
27 LACK OF INJECTION SITE ROTATION 651 0.3718
28 OCULAR SURFACE DISEASE 104 0.3701
29 IDIOPATHIC URTICARIA 369 0.3429
30 PERIORAL DERMATITIS 213 0.3354
31 CONJUNCTIVITIS 6096 0.3283
32 EYELID MARGIN CRUSTING 941 0.3253
33 EYELIDS PRURITUS 998 0.3200
34 SKIN SWELLING 2770 0.3188
35 SKIN HAEMORRHAGE 4685 0.3158
36 EYE PRURITUS 10590 0.3148
37 THERAPEUTIC RESPONSE SHORTENED 10265 0.3092
38 DYSHIDROTIC ECZEMA 215 0.2999
39 EYELID EXFOLIATION 231 0.2924
40 DRY EYE 14474 0.2897
41 CUTANEOUS T-CELL LYMPHOMA 357 0.2833
42 IMPAIRED QUALITY OF LIFE 3814 0.2650
43 SKIN DISCOMFORT 715 0.2648
44 SCRATCH 2588 0.2451
45 BLEPHARITIS 977 0.2433
46 DERMATITIS 5056 0.2410
47 REBOUND EFFECT 2520 0.2228
48 DRY SKIN 28839 0.2158
49 ECZEMA NUMMULAR 102 0.2086
50 NASAL OBSTRUCTION 390 0.2078
51 OFF LABEL USE OF DEVICE 277 0.2047
52 DRAINAGE 99 0.2008
53 FACIAL DISCOMFORT 141 0.1989
54 PERIORBITAL SWELLING 1114 0.1968
55 EYE ALLERGY 303 0.1955
56 ERYTHEMA OF EYELID 1055 0.1946
57 SKIN EXFOLIATION 16420 0.1944
58 HORDEOLUM 835 0.1928
59 EYELID IRRITATION 478 0.1904
60 KERATOCONUS 71 0.1888
61 HYPOSMIA 281 0.1867
62 EYE DISCHARGE 1928 0.1854
63 SWELLING OF EYELID 1156 0.1839
64 ORAL HERPES 3584 0.1834
65 ECZEMA ASTEATOTIC 86 0.1826
66 PRODUCT USE IN UNAPPROVED INDICATION 44555 0.1796
67 RASH ERYTHEMATOUS 8546 0.1786
68 ACCIDENTAL EXPOSURE TO PRODUCT 18392 0.1783
69 OCULAR HYPERAEMIA 8423 0.1773
70 ECZEMA HERPETICUM 82 0.1771
71 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 351 0.1720
72 PRURITUS 65143 0.1693
73 MOLLUSCUM CONTAGIOSUM 91 0.1685
74 INJECTION SITE SWELLING 12850 0.1675
75 INJECTION SITE URTICARIA 4106 0.1672
76 SKIN TEXTURE ABNORMAL 159 0.1660
77 FEAR OF INJECTION 1175 0.1645
78 EYE SYMPTOM 58 0.1625
79 THERAPEUTIC RESPONSE DECREASED 9832 0.1620
80 INFECTION PARASITIC 126 0.1611
81 ACTIVITIES OF DAILY LIVING DECREASED 101 0.1578
82 INJECTION SITE VESICLES 937 0.1547
83 INJECTION SITE RASH 4736 0.1542
84 ASTHMA 17440 0.1541
85 PRODUCT PREPARATION ERROR 3074 0.1495
86 SKIN DISCHARGE 57 0.1492
87 HAND-FOOT-AND-MOUTH DISEASE 122 0.1473
88 MILIARIA 249 0.1447
89 LIP ERYTHEMA 114 0.1427
90 RASH MACULAR 4850 0.1386
91 CONJUNCTIVITIS ALLERGIC 201 0.1356
92 SKIN DEPIGMENTATION 182 0.1333
93 ALLERGY TO ANIMAL 142 0.1332
94 INJECTION SITE PAIN 40378 0.1315
95 SINUS OPERATION 302 0.1266
96 INTERCEPTED PRODUCT STORAGE ERROR 452 0.1265
97 LACRIMATION INCREASED 3751 0.1240
98 EYE IRRITATION 6997 0.1214
99 INJECTION SITE DISCOMFORT 1278 0.1214
100 SUPERFICIAL INJURY OF EYE 131 0.1199
101 NASAL OPERATION 78 0.1139
102 EYE INFLAMMATION 1085 0.1136
103 HYPEREOSINOPHILIC SYNDROME 61 0.1128
104 PUSTULE 265 0.1117
105 FOOD ALLERGY 846 0.1095
106 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19713 0.1093
107 EOSINOPHIL COUNT INCREASED 903 0.1082
108 INTENTIONAL DOSE OMISSION 3087 0.1082
109 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 82 0.1073
110 EYE ULCER 61 0.1059
111 DERMATITIS ALLERGIC 1315 0.1044
112 LIP PRURITUS 89 0.1039
113 DRUG EFFECT LESS THAN EXPECTED 1538 0.1037
114 SKIN EROSION 333 0.1033
115 PRODUCT PRESCRIBING ISSUE 2241 0.1028
116 PERIORBITAL PAIN 87 0.1027
117 EYE INFECTION 1149 0.1017
118 TINEA INFECTION 111 0.1005
119 SLEEP DISORDER 7082 0.1002
120 INJECTION SITE INFLAMMATION 492 0.0987
121 INJECTION SITE IRRITATION 1249 0.0980
122 INJECTION SITE PRURITUS 6562 0.0979
123 PARANASAL SINUS DISCOMFORT 366 0.0966
124 KERATITIS 292 0.0960
125 INJECTION SITE ERYTHEMA 11789 0.0949
126 EXFOLIATIVE RASH 250 0.0948
127 RASH 41246 0.0945
128 SKIN BURNING SENSATION 6699 0.0934
129 SECRETION DISCHARGE 1168 0.0932
130 UPPER-AIRWAY COUGH SYNDROME 768 0.0931
131 ANOSMIA 1349 0.0931
132 SKIN WOUND 158 0.0929
133 DISCHARGE 128 0.0922
134 SEBORRHOEIC DERMATITIS 152 0.0919
135 PRODUCT PREPARATION ISSUE 596 0.0908
136 EYELID PAIN 184 0.0905
137 ALCOHOL INTOLERANCE 64 0.0901
138 SCAB 1013 0.0887
139 EOSINOPHILIC PNEUMONIA 278 0.0881
140 PRODUCT DOSE OMISSION ISSUE 25576 0.0869
141 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 230 0.0864
142 ROSACEA 398 0.0853
143 NASAL CONGESTION 4972 0.0845
144 EOSINOPHIL COUNT ABNORMAL 63 0.0843
145 SKIN MASS 562 0.0841
146 SYMPTOM RECURRENCE 499 0.0833
147 RASH PRURITIC 4513 0.0832
148 SENSITIVE SKIN 608 0.0823
149 DISCOMFORT 5020 0.0822
150 INJECTION SITE DISCOLOURATION 1021 0.0816
151 HERPES OPHTHALMIC 105 0.0794
152 OCULAR DISCOMFORT 892 0.0794
153 ALLERGY TO CHEMICALS 98 0.0787
154 RESPIRATION ABNORMAL 541 0.0784
155 INJECTION SITE HYPOAESTHESIA 112 0.0782
156 INJECTION SITE REACTION 5333 0.0774
157 CROUP INFECTIOUS 61 0.0774
158 PRODUCT USED FOR UNKNOWN INDICATION 97 0.0770
159 NASAL INFLAMMATION 81 0.0766
160 INJECTION SITE BRUISING 6113 0.0765
161 INJECTION SITE MASS 2817 0.0761
162 EYE SWELLING 2826 0.0759
163 EYE DISORDER 2497 0.0759
164 SKIN HYPERTROPHY 204 0.0725
165 CONDITION AGGRAVATED 21742 0.0714
166 ERYTHEMA 14686 0.0714
167 FOREIGN BODY IN EYE 68 0.0709
168 DANDRUFF 156 0.0705
169 SKIN HYPOPIGMENTATION 124 0.0701
170 HYPERAESTHESIA TEETH 88 0.0697
171 SKIN WARM 404 0.0694
172 IMPETIGO 102 0.0684
173 RESPIRATORY TRACT CONGESTION 1069 0.0672
174 SENSITIVITY TO WEATHER CHANGE 354 0.0672
175 SARS-COV-2 TEST POSITIVE 878 0.0664
176 VITILIGO 154 0.0656
177 NASAL PRURITUS 82 0.0654
178 ALLERGIC SINUSITIS 56 0.0653
179 CHRONIC SPONTANEOUS URTICARIA 75 0.0647
180 PIGMENTATION DISORDER 398 0.0644
181 SNEEZING 1443 0.0643
182 RHINORRHOEA 4117 0.0636
183 SKIN IRRITATION 2912 0.0635
184 INITIAL INSOMNIA 650 0.0633
185 T-CELL LYMPHOMA 72 0.0628
186 INJECTION SITE PARAESTHESIA 96 0.0625
187 INJECTION SITE SCAR 176 0.0617
188 PHARYNGITIS STREPTOCOCCAL 667 0.0616
189 SKIN DISCOLOURATION 2824 0.0614
190 DERMATITIS PSORIASIFORM 125 0.0611
191 ALOPECIA AREATA 107 0.0609
192 NASAL DISCHARGE DISCOLOURATION 84 0.0609
193 ODYNOPHAGIA 359 0.0601
194 MAST CELL ACTIVATION SYNDROME 84 0.0598
195 ACARODERMATITIS 65 0.0595
196 INCORRECT DOSE ADMINISTERED 13532 0.0592
197 ILLNESS 6097 0.0591
198 ASTHENOPIA 324 0.0589
199 FOREIGN BODY SENSATION IN EYES 375 0.0588
200 INJECTION SITE WARMTH 1210 0.0588
201 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1007 0.0587
202 FUNGAL SKIN INFECTION 231 0.0572
203 SKIN ATROPHY 329 0.0571
204 CHAPPED LIPS 248 0.0571
205 EYE PAIN 3221 0.0570
206 PRODUCT USE ISSUE 10724 0.0570
207 DERMATITIS EXFOLIATIVE GENERALISED 196 0.0563
208 WHEEZING 3282 0.0553
209 SINUS PAIN 129 0.0553
210 PRODUCTIVE COUGH 2614 0.0547
211 WISDOM TEETH REMOVAL 71 0.0538
212 EYELID DISORDER 124 0.0537
213 PAIN OF SKIN 1438 0.0534
214 NOROVIRUS INFECTION 77 0.0533
215 LIP EXFOLIATION 70 0.0526
216 PHARYNGEAL SWELLING 515 0.0526
217 DEVICE DISPENSING ERROR 62 0.0525
218 GENERAL PHYSICAL CONDITION ABNORMAL 356 0.0524
219 SKIN DISORDER 1746 0.0523
220 VISION BLURRED 7168 0.0522
221 THROAT CLEARING 195 0.0520
222 SUNBURN 383 0.0513
223 SKIN TIGHTNESS 240 0.0510
224 INJECTION SITE HYPERSENSITIVITY 158 0.0505
225 SKIN INDURATION 104 0.0501
226 SKIN PAPILLOMA 201 0.0501
227 ARTHRALGIA 20813 0.0500
228 DACRYOSTENOSIS ACQUIRED 64 0.0495
229 OROPHARYNGEAL DISCOMFORT 446 0.0493
230 EAR INFECTION 1307 0.0491
231 BLEPHAROSPASM 306 0.0485
232 BLISTER 2708 0.0482
233 EXPOSURE VIA BREAST MILK 191 0.0479
234 SERUM SICKNESS 133 0.0477
235 ARTHROPOD STING 79 0.0474
236 LICHEN PLANUS 110 0.0474
237 OTORRHOEA 82 0.0469
238 DERMATITIS CONTACT 534 0.0468
239 SINUS DISORDER 927 0.0468
240 EXPOSURE TO SARS-COV-2 79 0.0464
241 RASH VESICULAR 224 0.0463
242 DARK CIRCLES UNDER EYES 68 0.0462
243 CORNEAL ABRASION 63 0.0459
244 ARTHROPOD BITE 339 0.0457
245 URTICARIA 7615 0.0454
246 TOOTHACHE 821 0.0453
247 MIDDLE EAR EFFUSION 99 0.0448
248 SEASONAL ALLERGY 629 0.0444
249 PEMPHIGOID 335 0.0443
250 EXTRA DOSE ADMINISTERED 1796 0.0443
251 ORAL MUCOSAL ERUPTION 68 0.0442
252 RESPIRATORY SYNCYTIAL VIRUS INFECTION 385 0.0442
253 ERYTHEMA NODOSUM 155 0.0441
254 COUGH 12309 0.0438
255 COVID-19 7649 0.0436
256 RHINALGIA 119 0.0433
257 RESPIRATORY SYMPTOM 123 0.0432
258 NASAL DRYNESS 271 0.0432
259 MIDDLE INSOMNIA 802 0.0429
260 EXCESSIVE EYE BLINKING 63 0.0426
261 LIP BLISTER 116 0.0426
262 SKIN ULCER 1099 0.0425
263 SINUSITIS 4327 0.0422
264 CHEILITIS 227 0.0419
265 PRODUCT DOSE OMISSION 2734 0.0418
266 PAROSMIA 315 0.0417
267 EAR SWELLING 88 0.0415
268 NECK SURGERY 96 0.0412
269 SKIN WRINKLING 112 0.0412
270 SKIN LESION 1130 0.0412
271 INJECTION SITE OEDEMA 70 0.0407
272 VITREOUS FLOATERS 399 0.0405
273 SPINAL OPERATION 493 0.0400
274 SHOULDER OPERATION 170 0.0397
275 HERPES VIRUS INFECTION 229 0.0397
276 NASOPHARYNGITIS 7279 0.0394
277 CHRONIC SINUSITIS 148 0.0394
278 SKIN INFECTION 441 0.0393
279 LIP DRY 357 0.0393
280 SPUTUM INCREASED 85 0.0393
281 ANKLE OPERATION 58 0.0392
282 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2031 0.0389
283 HYPOGEUSIA 76 0.0387
284 OROPHARYNGEAL PAIN 3559 0.0384
285 INJECTION SITE DISCHARGE 206 0.0383
286 INJECTION SITE INDURATION 491 0.0378
287 SINUS CONGESTION 509 0.0376
288 JOINT NOISE 73 0.0371
289 PRODUCT STORAGE ERROR 3253 0.0371
290 ROTATOR CUFF REPAIR 65 0.0371
291 RASH PAPULAR 831 0.0370
292 DEVICE OPERATIONAL ISSUE 159 0.0369
293 SLEEP DEFICIT 78 0.0369
294 OXYGEN CONSUMPTION INCREASED 88 0.0368
295 SKIN ABRASION 174 0.0368
296 THERAPEUTIC RESPONSE UNEXPECTED 1640 0.0365
297 RESPIRATORY TRACT INFECTION VIRAL 85 0.0365
298 THERAPEUTIC RESPONSE DELAYED 102 0.0364
299 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 221 0.0363
300 LIP PAIN 104 0.0362
301 SINUS HEADACHE 215 0.0362
302 DEVICE USE ISSUE 629 0.0359
303 EAR PRURITUS 126 0.0359
304 INJECTION SITE NODULE 395 0.0359
305 KNEE OPERATION 352 0.0357
306 PRODUCT PRESCRIBING ERROR 852 0.0357
307 STREPTOCOCCAL INFECTION 199 0.0357
308 INFLUENZA 3975 0.0356
309 INCORRECT DOSE ADMINISTERED BY PRODUCT 57 0.0356
310 SKIN PLAQUE 298 0.0353
311 EAR DISCOMFORT 360 0.0350
312 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1683 0.0350
313 SHOULDER FRACTURE 57 0.0348
314 PARANASAL SINUS HYPERSECRETION 133 0.0348
315 PHOTOPHOBIA 654 0.0347
316 INJECTION SITE INDENTATION 75 0.0346
317 EYE OPERATION 158 0.0343
318 MATERNAL EXPOSURE DURING BREAST FEEDING 138 0.0340
319 SKIN HYPERPIGMENTATION 292 0.0339
320 SURGERY 1979 0.0337
321 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 617 0.0336
322 MULTIPLE ALLERGIES 262 0.0334
323 LIMB OPERATION 160 0.0333
324 FACIAL PAIN 297 0.0332
325 ABNORMAL SENSATION IN EYE 143 0.0332
326 EOSINOPHIL COUNT DECREASED 79 0.0332
327 UPPER RESPIRATORY TRACT CONGESTION 96 0.0331
328 HERNIA REPAIR 86 0.0331
329 EAR CONGESTION 89 0.0328
330 HYPERSENSITIVITY 6076 0.0327
331 PHOTOSENSITIVITY REACTION 540 0.0327
332 APHTHOUS ULCER 253 0.0326
333 RESPIRATORY TRACT INFECTION 849 0.0326
334 PRODUCT STORAGE ISSUE 123 0.0324
335 ATYPICAL PNEUMONIA 97 0.0324
336 NASAL SEPTUM DEVIATION 63 0.0322
337 FOOT OPERATION 159 0.0321
338 ULCERATIVE KERATITIS 88 0.0321
339 NASAL DISORDER 85 0.0319
340 JOINT STIFFNESS 836 0.0318
341 SUSPECTED COVID-19 105 0.0318
342 SCAR 536 0.0313
343 WEIGHT ABNORMAL 75 0.0312
344 FURUNCLE 247 0.0311
345 VISUAL IMPAIRMENT 3858 0.0311
346 RHINITIS ALLERGIC 138 0.0310
347 EOSINOPHILIA 541 0.0308
348 INFECTIOUS MONONUCLEOSIS 69 0.0307
349 VIRAL INFECTION 1008 0.0303
350 SWELLING 2805 0.0299
351 EYE CONTUSION 63 0.0298
352 GASTROENTERITIS VIRAL 535 0.0296
353 UPPER RESPIRATORY TRACT INFECTION 1369 0.0296
354 DECREASED ACTIVITY 319 0.0295
355 SKIN LACERATION 318 0.0292
356 ATTENTION DEFICIT HYPERACTIVITY DISORDER 123 0.0292
357 AFFECTIVE DISORDER 229 0.0291
358 SKIN ODOUR ABNORMAL 114 0.0289
359 DYSPHAGIA 2738 0.0288
360 BLOOD BLISTER 90 0.0288
361 SHOULDER ARTHROPLASTY 77 0.0286
362 DYSPNOEA 16168 0.0285
363 BLOOD IMMUNOGLOBULIN E INCREASED 69 0.0285
364 SKIN INJURY 94 0.0283
365 PAPULE 199 0.0282
366 SPUTUM DISCOLOURED 266 0.0280
367 NEEDLE ISSUE 812 0.0279
368 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 180 0.0277
369 REGURGITATION 95 0.0276
370 INJURY ASSOCIATED WITH DEVICE 562 0.0276
371 BURNING SENSATION 1931 0.0275
372 INFLAMMATION 1417 0.0274
373 LYMPHADENOPATHY 970 0.0274
374 MYOPIA 65 0.0273
375 SWELLING FACE 1767 0.0271
376 PULMONARY PAIN 79 0.0270
377 DRY THROAT 274 0.0269
378 MUSCULOSKELETAL DISCOMFORT 460 0.0267
379 BRAIN FOG 418 0.0266
380 EXPOSURE TO TOXIC AGENT 85 0.0265
381 TENDERNESS 276 0.0265
382 EAR PAIN 512 0.0263
383 ORAL PRURITUS 60 0.0261
384 SKIN REACTION 368 0.0261
385 HERPES SIMPLEX 169 0.0260
386 FUNGAL INFECTION 865 0.0259
387 GALLBLADDER OPERATION 105 0.0259
388 HAEMATOLOGICAL INFECTION 63 0.0257
389 DEVICE DEFECTIVE 446 0.0257
390 MYALGIA 4340 0.0255
391 APHONIA 356 0.0255
392 INJECTION SITE HAEMORRHAGE 2037 0.0255
393 BRONCHITIS 1883 0.0254
394 POLYMYALGIA RHEUMATICA 80 0.0252
395 CHEST DISCOMFORT 2568 0.0251
396 PRURITUS GENITAL 59 0.0250
397 HERPES ZOSTER 1439 0.0250
398 FOOD POISONING 134 0.0250
399 KNEE ARTHROPLASTY 524 0.0249
400 THERAPEUTIC PRODUCT EFFECT DECREASED 1111 0.0248
401 EMERGENCY CARE 75 0.0247
402 DRUG INEFFECTIVE 32504 0.0246
403 RHINOVIRUS INFECTION 95 0.0244
404 FORMICATION 168 0.0241
405 INCORRECT DOSAGE ADMINISTERED 118 0.0241
406 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1318 0.0240
407 PERIPHERAL SWELLING 3667 0.0238
408 MATERNAL EXPOSURE DURING PREGNANCY 2117 0.0237
409 ANIMAL BITE 63 0.0236
410 INTENTIONAL PRODUCT MISUSE 2051 0.0234
411 SPINAL FUSION SURGERY 95 0.0234
412 HYPERKERATOSIS 128 0.0232
413 DYSPNOEA EXERTIONAL 868 0.0230
414 QUALITY OF LIFE DECREASED 309 0.0230
415 THERAPEUTIC PRODUCT EFFECT DELAYED 105 0.0230
416 ACNE 1738 0.0229
417 LIGAMENT SPRAIN 223 0.0225
418 HIP SURGERY 122 0.0225
419 CARDIAC OPERATION 193 0.0224
420 CATARACT OPERATION 133 0.0224
421 ONYCHOMYCOSIS 98 0.0223
422 DECREASED INTEREST 131 0.0222
423 CONJUNCTIVAL HYPERAEMIA 79 0.0221
424 APPENDICECTOMY 79 0.0221
425 MENOPAUSE 57 0.0221
426 MUSCLE STRAIN 191 0.0221
427 DERMATITIS ACNEIFORM 134 0.0220
428 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1560 0.0219
429 CONCUSSION 169 0.0218
430 NODULE 282 0.0216
431 ACCIDENT 258 0.0216
432 IMMUNE SYSTEM DISORDER 282 0.0214
433 GINGIVAL PAIN 169 0.0212
434 THROAT TIGHTNESS 573 0.0212
435 EXPOSURE DURING PREGNANCY 1295 0.0208
436 PSORIASIS 2711 0.0207
437 LOSS OF THERAPEUTIC RESPONSE 66 0.0207
438 MATERNAL EXPOSURE TIMING UNSPECIFIED 77 0.0205
439 AUTOIMMUNE DISORDER 199 0.0204
440 RHINITIS 164 0.0203
441 LIP SWELLING 676 0.0203
442 LIMB INJURY 549 0.0202
443 ONYCHOCLASIS 139 0.0202
444 LYME DISEASE 67 0.0201
445 LOCALISED INFECTION 483 0.0200
446 THROAT IRRITATION 894 0.0199
447 HOSPITALISATION 3061 0.0199
448 ALOPECIA 3912 0.0199
449 INFECTION 2883 0.0199
450 CONTUSION 1907 0.0198
451 OESOPHAGEAL DISORDER 76 0.0197
452 ASTHMATIC CRISIS 72 0.0197
453 ARTHRITIS 1548 0.0197
454 EAR DISORDER 90 0.0196
455 PRODUCT DISPENSING ISSUE 84 0.0196
456 WEIGHT INCREASED 4375 0.0195
457 NERVE COMPRESSION 180 0.0195
458 BRONCHIECTASIS 131 0.0194
459 HYSTERECTOMY 168 0.0194
460 STRABISMUS 57 0.0194
461 CHOKING 374 0.0192
462 MOUTH SWELLING 110 0.0190
463 HYPERPHAGIA 76 0.0190
464 UNEVALUABLE EVENT 1438 0.0190
465 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 555 0.0189
466 INJECTION SITE INJURY 105 0.0189
467 TRIGGER FINGER 77 0.0188
468 HIP ARTHROPLASTY 287 0.0187
469 HAND FRACTURE 132 0.0186
470 MENSTRUAL DISORDER 152 0.0183
471 POLYP 120 0.0183
472 LIMB DISCOMFORT 566 0.0183
473 BACK DISORDER 296 0.0182
474 POLYMENORRHOEA 63 0.0182
475 STAPHYLOCOCCAL INFECTION 595 0.0180
476 GASTRITIS 474 0.0180
477 MOOD ALTERED 491 0.0180
478 AUTOIMMUNE THYROIDITIS 68 0.0180
479 CARDIAC PACEMAKER INSERTION 107 0.0179
480 DYSPHONIA 1049 0.0179
481 CATARACT 1068 0.0179
482 TEMPERATURE INTOLERANCE 183 0.0177
483 GLAUCOMA 340 0.0176
484 INJECTION SITE INFECTION 58 0.0176
485 CHOKING SENSATION 97 0.0176
486 HAIR GROWTH ABNORMAL 121 0.0175
487 SNORING 66 0.0174
488 GINGIVAL SWELLING 77 0.0174
489 PAIN IN EXTREMITY 5133 0.0174
490 NASAL DISCOMFORT 138 0.0174
491 WOUND 485 0.0173
492 PRODUCT TEMPERATURE EXCURSION ISSUE 89 0.0173
493 SARCOIDOSIS 82 0.0172
494 ORAL PAIN 384 0.0171
495 OFF LABEL USE 15002 0.0171
496 INSOMNIA 4559 0.0171
497 PSYCHIATRIC SYMPTOM 126 0.0171
498 TOOTH INFECTION 224 0.0170
499 CHEMOTHERAPY 64 0.0169
500 MIGRAINE 1615 0.0169
501 MACULAR DEGENERATION 202 0.0169
502 PAIN 10311 0.0168
503 PARAESTHESIA 2638 0.0168
504 SCIATICA 265 0.0166
505 BACK INJURY 180 0.0165
506 BLOOD PRESSURE ABNORMAL 328 0.0165
507 PHOTOPSIA 104 0.0164
508 NEURALGIA 400 0.0164
509 NAIL DISCOLOURATION 64 0.0163
510 POOR QUALITY PRODUCT ADMINISTERED 170 0.0161
511 AGEUSIA 402 0.0161
512 HEADACHE 10102 0.0161
513 RESPIRATORY DISORDER 473 0.0158
514 POST PROCEDURAL INFECTION 128 0.0157
515 CORONAVIRUS INFECTION 104 0.0157
516 TONSILLITIS 82 0.0157
517 JOINT SWELLING 1872 0.0155
518 MENISCUS INJURY 95 0.0154
519 FEELING HOT 947 0.0154
520 OESOPHAGEAL PAIN 61 0.0154
521 RETCHING 327 0.0153
522 HYPOAESTHESIA 2292 0.0153
523 SPINAL STENOSIS 63 0.0152
524 EYE HAEMORRHAGE 202 0.0151
525 RASH PUSTULAR 110 0.0151
526 PYREXIA 5183 0.0150
527 CHOLECYSTECTOMY 171 0.0150
528 MENTAL STATUS CHANGES 415 0.0149
529 PULMONARY CONGESTION 197 0.0149
530 EPISTAXIS 1115 0.0149
531 ANKLE FRACTURE 230 0.0148
532 GAIT INABILITY 496 0.0148
533 TASTE DISORDER 300 0.0148
534 CYST 183 0.0147
535 PNEUMONIA 4748 0.0147
536 BACK PAIN 3406 0.0146
537 THERMAL BURN 104 0.0146
538 CANDIDA INFECTION 247 0.0146
539 INFLUENZA LIKE ILLNESS 1202 0.0146
540 PARAESTHESIA ORAL 210 0.0145
541 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 676 0.0145
542 NECK PAIN 806 0.0144
543 VULVOVAGINAL PRURITUS 73 0.0144
544 BLOOD IRON DECREASED 171 0.0144
545 INCREASED APPETITE 273 0.0143
546 NAIL DISORDER 125 0.0143
547 HEAD DISCOMFORT 252 0.0142
548 IMMUNE THROMBOCYTOPENIA 65 0.0142
549 PHARYNGITIS 176 0.0142
550 VASCULITIS 165 0.0141
551 INJECTION SITE EXTRAVASATION 174 0.0141
552 BACTERIAL INFECTION 263 0.0141
553 MUSCLE TIGHTNESS 228 0.0141
554 GOUT 252 0.0140
555 HERNIA 269 0.0139
556 TONGUE DISCOMFORT 59 0.0139
557 TENDONITIS 209 0.0135
558 SLEEP APNOEA SYNDROME 257 0.0135
559 JOINT INJURY 287 0.0134
560 PETECHIAE 140 0.0134
561 ANAPHYLACTIC REACTION 733 0.0133
562 URINARY TRACT INFECTION 2255 0.0132
563 UPPER LIMB FRACTURE 263 0.0132
564 WRIST FRACTURE 158 0.0132
565 HEAVY MENSTRUAL BLEEDING 118 0.0131
566 PURPURA 116 0.0131
567 DRY MOUTH 1062 0.0131
568 PULMONARY FUNCTION TEST DECREASED 57 0.0130
569 PNEUMONIA BACTERIAL 119 0.0130
570 LOWER LIMB FRACTURE 249 0.0129
571 PULMONARY MASS 193 0.0129
572 ULCER 206 0.0129
573 ROAD TRAFFIC ACCIDENT 540 0.0129
574 STENT PLACEMENT 104 0.0129
575 INCORRECT DOSE ADMINISTERED BY DEVICE 338 0.0129
576 EMPHYSEMA 130 0.0129
577 RIB FRACTURE 264 0.0128
578 BONE PAIN 750 0.0128
579 MENTAL DISORDER 557 0.0128
580 KIDNEY INFECTION 251 0.0128
581 NEPHROLITHIASIS 586 0.0128
582 ORAL DISCOMFORT 177 0.0127
583 SENSATION OF FOREIGN BODY 107 0.0127
584 MUSCULOSKELETAL STIFFNESS 1112 0.0127
585 DIVERTICULITIS 351 0.0127
586 ABDOMINAL PAIN UPPER 2602 0.0126
587 GASTROOESOPHAGEAL REFLUX DISEASE 1017 0.0126
588 TOOTH EXTRACTION 157 0.0126
589 INCORRECT PRODUCT ADMINISTRATION DURATION 273 0.0126
590 FOOT FRACTURE 238 0.0125
591 CELLULITIS 632 0.0125
592 RETINAL DETACHMENT 115 0.0125
593 ABDOMINAL DISCOMFORT 2084 0.0124
594 VITAMIN D DECREASED 106 0.0124
595 GROIN PAIN 108 0.0123
596 INCREASED TENDENCY TO BRUISE 113 0.0123
597 CARDIAC FLUTTER 79 0.0122
598 GLUCOSE TOLERANCE IMPAIRED 71 0.0120
599 MADAROSIS 139 0.0120
600 DEPRESSED MOOD 630 0.0119
601 OESOPHAGITIS 130 0.0119
602 LUNG DISORDER 582 0.0119
603 LYMPHOEDEMA 82 0.0118
604 AUTISM SPECTRUM DISORDER 65 0.0118
605 FATIGUE 9119 0.0117
606 GINGIVITIS 63 0.0117
607 CHEST PAIN 2156 0.0116
608 ROTATOR CUFF SYNDROME 149 0.0116
609 MUSCULOSKELETAL CHEST PAIN 179 0.0116
610 BREATH SOUNDS ABNORMAL 57 0.0115
611 EATING DISORDER 246 0.0115
612 CARPAL TUNNEL SYNDROME 161 0.0115
613 VERTIGO 698 0.0114
614 INTRAOCULAR PRESSURE INCREASED 146 0.0114
615 MOUTH ULCERATION 240 0.0114
616 IMMUNOSUPPRESSION 100 0.0113
617 DIZZINESS 5649 0.0113
618 NERVE INJURY 125 0.0112
619 MUSCLE SPASMS 2061 0.0112
620 DECREASED IMMUNE RESPONSIVENESS 110 0.0112
621 POLYARTHRITIS 59 0.0112
622 BOWEL MOVEMENT IRREGULARITY 85 0.0111
623 FOLLICULITIS 116 0.0111
624 URINE ODOUR ABNORMAL 65 0.0110
625 ORAL DISORDER 81 0.0110
626 PSEUDOMONAS INFECTION 94 0.0110
627 PAIN IN JAW 308 0.0109
628 HYPOACUSIS 467 0.0108
629 SCREAMING 69 0.0108
630 OXYGEN SATURATION DECREASED 607 0.0108
631 HEART RATE ABNORMAL 60 0.0107
632 COVID-19 PNEUMONIA 127 0.0107
633 DIPLOPIA 279 0.0107
634 HYPERHIDROSIS 1378 0.0107
635 LYMPHOMA 165 0.0107
636 GASTROINTESTINAL DISORDER 955 0.0106
637 CYSTIC FIBROSIS 59 0.0106
638 FRUSTRATION TOLERANCE DECREASED 86 0.0106
639 PLEURISY 63 0.0106
640 SLUGGISHNESS 108 0.0106
641 NEOPLASM MALIGNANT 701 0.0105
642 GRIP STRENGTH DECREASED 92 0.0104
643 DIZZINESS POSTURAL 101 0.0104
644 IMMUNODEFICIENCY 154 0.0103
645 SWOLLEN TONGUE 321 0.0103
646 ORAL CANDIDIASIS 135 0.0102
647 HYPERSOMNIA 293 0.0102
648 SKIN CANCER 220 0.0102
649 GAIT DISTURBANCE 1940 0.0101
650 PRODUCT DISPENSING ERROR 219 0.0100
651 POOR QUALITY SLEEP 216 0.0100
652 GASTROINTESTINAL PAIN 110 0.0100
653 FLUSHING 1014 0.0100
654 BLINDNESS TRANSIENT 73 0.0099
655 NIGHT SWEATS 316 0.0098
656 CHILLS 1149 0.0098
657 MENSTRUATION DELAYED 105 0.0097
658 EMOTIONAL DISORDER 298 0.0097
659 ARTHROPATHY 535 0.0096
660 HIP FRACTURE 309 0.0096
661 HYPOKINESIA 138 0.0095
662 HYPOAESTHESIA ORAL 143 0.0095
663 FEEDING DISORDER 191 0.0094
664 FIBROMYALGIA 228 0.0094
665 MALAISE 4105 0.0094
666 TOOTH ABSCESS 95 0.0093
667 STOMATITIS 562 0.0093
668 MUSCLE DISORDER 75 0.0093
669 TENDON PAIN 70 0.0092
670 SQUAMOUS CELL CARCINOMA 87 0.0092
671 HEREDITARY ANGIOEDEMA 98 0.0091
672 HEAD INJURY 289 0.0091
673 UVEITIS 123 0.0091
674 BURSITIS 110 0.0091
675 FALL 3016 0.0091
676 HOSPICE CARE 89 0.0090
677 MEMORY IMPAIRMENT 1210 0.0088
678 GENERALISED OEDEMA 109 0.0088
679 PRESYNCOPE 214 0.0088
680 HAEMORRHAGE 917 0.0088
681 WEIGHT DECREASED 2443 0.0087
682 WEIGHT FLUCTUATION 91 0.0087
683 BLINDNESS UNILATERAL 122 0.0086
684 HEART RATE INCREASED 855 0.0086
685 PANIC ATTACK 314 0.0086
686 JOINT DISLOCATION 91 0.0086
687 CRYING 311 0.0085
688 BREAST CANCER FEMALE 228 0.0085
689 ADVERSE DRUG REACTION 765 0.0085
690 PELVIC FRACTURE 66 0.0085
691 FEELING ABNORMAL 2029 0.0085
692 ABSCESS 135 0.0085
693 ANXIETY 2407 0.0084
694 ABDOMINAL DISTENSION 882 0.0084
695 VISUAL FIELD DEFECT 61 0.0084
696 MUSCLE TWITCHING 194 0.0084
697 DYSPEPSIA 826 0.0084
698 LEUKAEMIA 79 0.0084
699 EYE MOVEMENT DISORDER 57 0.0083
700 THYROID DISORDER 128 0.0083
701 CYSTITIS 264 0.0083
702 COLD SWEAT 146 0.0083
703 LETHARGY 476 0.0083
704 OBSTRUCTIVE AIRWAYS DISORDER 92 0.0083
705 GASTROINTESTINAL INFECTION 74 0.0082
706 LOWER RESPIRATORY TRACT INFECTION 375 0.0082
707 APPENDICITIS 77 0.0082
708 DRUG ERUPTION 146 0.0082
709 PULMONARY THROMBOSIS 89 0.0082
710 PROCEDURAL PAIN 226 0.0081
711 BLOOD SODIUM DECREASED 153 0.0081
712 SENSORY DISTURBANCE 130 0.0081
713 CARDIAC DISORDER 756 0.0081
714 HYPERAESTHESIA 66 0.0080
715 MOBILITY DECREASED 576 0.0080
716 PERIPHERAL COLDNESS 110 0.0080
717 INTERVERTEBRAL DISC PROTRUSION 175 0.0080
718 WHITE BLOOD CELL COUNT INCREASED 304 0.0079
719 SYSTEMIC LUPUS ERYTHEMATOSUS 279 0.0079
720 GALLBLADDER DISORDER 140 0.0078
721 FEELING COLD 218 0.0078
722 HIATUS HERNIA 101 0.0078
723 EYELID PTOSIS 79 0.0078
724 DIARRHOEA 4992 0.0077
725 BRONCHOSPASM 110 0.0077
726 SPINAL PAIN 90 0.0077
727 DEPRESSION 1745 0.0077
728 TINNITUS 352 0.0077
729 DEMENTIA 213 0.0076
730 IMPAIRED DRIVING ABILITY 86 0.0076
731 HIDRADENITIS 69 0.0076
732 PNEUMOTHORAX 117 0.0074
733 IRRITABILITY 441 0.0073
734 EYELID OEDEMA 85 0.0073
735 FULL BLOOD COUNT ABNORMAL 77 0.0073
736 BLINDNESS 296 0.0073
737 DYSSTASIA 212 0.0073
738 DEVICE ISSUE 651 0.0073
739 HOT FLUSH 546 0.0072
740 BEDRIDDEN 95 0.0072
741 FLATULENCE 409 0.0072
742 HELICOBACTER INFECTION 74 0.0072
743 FLUID RETENTION 366 0.0072
744 MENSTRUATION IRREGULAR 192 0.0072
745 NERVOUSNESS 374 0.0072
746 FACIAL PARALYSIS 61 0.0071
747 COELIAC DISEASE 70 0.0071
748 MOVEMENT DISORDER 229 0.0071
749 NAUSEA 5638 0.0071
750 THROMBOSIS 573 0.0071
751 ABORTION SPONTANEOUS 285 0.0071
752 THIRST 127 0.0071
753 IMPAIRED WORK ABILITY 150 0.0070
754 MASS 98 0.0070
755 RESTLESS LEGS SYNDROME 127 0.0070
756 PRODUCT ADMINISTRATION ERROR 141 0.0070
757 TOOTH DISORDER 155 0.0070
758 SPINAL DISORDER 66 0.0070
759 THERAPY CESSATION 357 0.0069
760 POLLAKIURIA 289 0.0069
761 MUSCULAR WEAKNESS 782 0.0069
762 VOMITING 3144 0.0067
763 HEART RATE IRREGULAR 151 0.0067
764 IMPAIRED GASTRIC EMPTYING 91 0.0067
765 RENAL DISORDER 311 0.0067
766 IRRITABLE BOWEL SYNDROME 142 0.0066
767 ERUCTATION 128 0.0066
768 TRANSIENT ISCHAEMIC ATTACK 223 0.0066
769 ATRIAL FIBRILLATION 642 0.0066
770 DECREASED APPETITE 1528 0.0066
771 THERAPY INTERRUPTED 470 0.0066
772 CEREBROVASCULAR ACCIDENT 1105 0.0065
773 BODY TEMPERATURE INCREASED 133 0.0065
774 TREATMENT FAILURE 538 0.0065
775 ASTHENIA 2436 0.0065
776 EXOSTOSIS 59 0.0065
777 HAEMOPTYSIS 180 0.0064
778 BRAIN NEOPLASM 59 0.0064
779 MALIGNANT MELANOMA 86 0.0064
780 WOUND INFECTION 70 0.0064
781 BREAST PAIN 68 0.0064
782 TENDON RUPTURE 78 0.0063
783 OVARIAN CYST 63 0.0063
784 NEUROPATHY PERIPHERAL 599 0.0063
785 COLITIS 238 0.0063
786 POST PROCEDURAL COMPLICATION 120 0.0062
787 HUNGER 87 0.0062
788 DYSURIA 229 0.0062
789 INTERNAL HAEMORRHAGE 71 0.0062
790 COLON CANCER 92 0.0062
791 LOSS OF CONSCIOUSNESS 790 0.0062
792 BLOOD URINE PRESENT 117 0.0062
793 SYNCOPE 615 0.0061
794 PALPITATIONS 718 0.0061
795 DIALYSIS 86 0.0061
796 DIABETES MELLITUS 461 0.0060
797 SPINAL FRACTURE 121 0.0060
798 FEELING JITTERY 115 0.0060
799 HYPERTENSION 1277 0.0060
800 NO ADVERSE EVENT 1083 0.0060
801 PULMONARY OEDEMA 266 0.0059
802 TOOTH FRACTURE 65 0.0059
803 ABDOMINAL PAIN 1369 0.0059
804 BLADDER DISORDER 58 0.0058
805 OSTEOPOROSIS 240 0.0058
806 CHROMATURIA 131 0.0058
807 OSTEOARTHRITIS 244 0.0057
808 RENAL PAIN 61 0.0057
809 BLOOD POTASSIUM DECREASED 173 0.0057
810 PERICARDIAL EFFUSION 133 0.0057
811 ANGIOEDEMA 253 0.0057
812 SOMNOLENCE 1151 0.0057
813 GINGIVAL BLEEDING 78 0.0057
814 GASTROENTERITIS 83 0.0057
815 ADVERSE REACTION 75 0.0057
816 CONSTIPATION 1229 0.0056
817 ADRENAL INSUFFICIENCY 68 0.0056
818 INFUSION SITE PAIN 72 0.0056
819 BLOOD PRESSURE INCREASED 853 0.0056
820 BLOOD CHOLESTEROL INCREASED 260 0.0056
821 GLOSSODYNIA 124 0.0055
822 MOOD SWINGS 176 0.0055
823 IMPAIRED HEALING 181 0.0055
824 HAIR TEXTURE ABNORMAL 73 0.0055
825 LUNG NEOPLASM MALIGNANT 224 0.0054
826 GLYCOSYLATED HAEMOGLOBIN INCREASED 137 0.0054
827 NEOPLASM 62 0.0054
828 MICTURITION URGENCY 61 0.0053
829 BALANCE DISORDER 460 0.0053
830 DENTAL CARIES 58 0.0052
831 DEAFNESS 137 0.0052
832 INJECTION SITE HAEMATOMA 76 0.0052
833 FRACTURE 99 0.0052
834 DISTURBANCE IN ATTENTION 282 0.0052
835 ASPIRATION 57 0.0052
836 PSORIATIC ARTHROPATHY 211 0.0052
837 PERICARDITIS 87 0.0052
838 SPEECH DISORDER 270 0.0051
839 DEHYDRATION 684 0.0051
840 RHEUMATOID ARTHRITIS 574 0.0051
841 LEUKOCYTOSIS 91 0.0050
842 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1015 0.0050
843 SEIZURE 577 0.0050
844 CLOSTRIDIUM DIFFICILE INFECTION 109 0.0050
845 BLOOD GLUCOSE ABNORMAL 92 0.0050
846 OEDEMA 266 0.0049
847 BASAL CELL CARCINOMA 76 0.0049
848 DYSMENORRHOEA 64 0.0048
849 ANAPHYLACTIC SHOCK 124 0.0048
850 DRUG DOSE OMISSION BY DEVICE 372 0.0047
851 FREQUENT BOWEL MOVEMENTS 127 0.0047
852 PNEUMONITIS 128 0.0047
853 PANCREATITIS 248 0.0047
854 AMENORRHOEA 82 0.0047
855 COLITIS ULCERATIVE 209 0.0047
856 RESTLESSNESS 169 0.0046
857 FAECES DISCOLOURED 100 0.0046
858 HEART RATE DECREASED 160 0.0046
859 DEVICE MECHANICAL ISSUE 62 0.0045
860 PALLOR 123 0.0045
861 TREMOR 744 0.0045
862 TREATMENT NONCOMPLIANCE 245 0.0045
863 OSTEOMYELITIS 81 0.0045
864 HEPATIC STEATOSIS 83 0.0045
865 GENERAL PHYSICAL HEALTH DETERIORATION 515 0.0044
866 ABNORMAL DREAMS 122 0.0044
867 DEVICE LEAKAGE 191 0.0044
868 ANKYLOSING SPONDYLITIS 58 0.0044
869 CONTRAINDICATED PRODUCT ADMINISTERED 133 0.0044
870 ANGER 148 0.0044
871 SEPSIS 484 0.0043
872 CARDIAC FAILURE CONGESTIVE 344 0.0043
873 BLOOD PRESSURE DECREASED 283 0.0043
874 HAEMATOMA 109 0.0042
875 INSURANCE ISSUE 64 0.0042
876 MYOCARDIAL INFARCTION 725 0.0042
877 FACE OEDEMA 69 0.0041
878 PRODUCT USE COMPLAINT 64 0.0041
879 GASTRIC ULCER 77 0.0040
880 DEVICE MALFUNCTION 280 0.0040
881 AMNESIA 252 0.0039
882 THERAPY NON-RESPONDER 174 0.0039
883 BLOOD GLUCOSE DECREASED 185 0.0038
884 RESPIRATORY DISTRESS 106 0.0038
885 BLOOD POTASSIUM INCREASED 62 0.0038
886 PULMONARY FIBROSIS 73 0.0038
887 OEDEMA PERIPHERAL 462 0.0038
888 MUSCULOSKELETAL DISORDER 72 0.0038
889 URINARY INCONTINENCE 112 0.0038
890 HAEMORRHOIDS 73 0.0037
891 HYPOXIA 131 0.0037
892 APHASIA 112 0.0037
893 ERECTILE DYSFUNCTION 95 0.0037
894 NIGHTMARE 127 0.0037
895 SYRINGE ISSUE 64 0.0037
896 PRURITUS GENERALISED 79 0.0036
897 HEPATIC ENZYME INCREASED 249 0.0036
898 HAEMATOCHEZIA 201 0.0036
899 CHOLELITHIASIS 119 0.0036
900 CARDIAC FAILURE 290 0.0036
901 INJURY 252 0.0036
902 BONE DISORDER 63 0.0035
903 DISEASE RECURRENCE 163 0.0034
904 ABDOMINAL PAIN LOWER 86 0.0034
905 LIVER FUNCTION TEST INCREASED 73 0.0034
906 NERVOUS SYSTEM DISORDER 106 0.0034
907 THINKING ABNORMAL 63 0.0034
908 RASH MACULO-PAPULAR 75 0.0034
909 INTESTINAL OBSTRUCTION 127 0.0034
910 TACHYCARDIA 294 0.0033
911 MUSCULOSKELETAL PAIN 173 0.0033
912 HEPATIC CIRRHOSIS 62 0.0033
913 ILL-DEFINED DISORDER 200 0.0033
914 DYSGEUSIA 243 0.0033
915 LIVER DISORDER 145 0.0033
916 HYPOTENSION 616 0.0031
917 DYSARTHRIA 115 0.0031
918 C-REACTIVE PROTEIN INCREASED 109 0.0030
919 HYPOTHYROIDISM 95 0.0030
920 MENTAL IMPAIRMENT 72 0.0030
921 DISABILITY 58 0.0029
922 RASH GENERALISED 75 0.0029
923 TYPE 2 DIABETES MELLITUS 97 0.0029
924 PULMONARY HYPERTENSION 60 0.0029
925 DEVICE USE ERROR 100 0.0029
926 DRUG INTOLERANCE 275 0.0028
927 BLOOD GLUCOSE INCREASED 533 0.0028
928 FEMUR FRACTURE 87 0.0028
929 PLEURAL EFFUSION 170 0.0028
930 DEVICE DELIVERY SYSTEM ISSUE 75 0.0027
931 DISORIENTATION 108 0.0027
932 ANGINA PECTORIS 77 0.0027
933 BLOOD PRESSURE FLUCTUATION 64 0.0027
934 DEVICE DIFFICULT TO USE 175 0.0026
935 INTENTIONAL PRODUCT USE ISSUE 230 0.0026
936 RED BLOOD CELL COUNT DECREASED 75 0.0026
937 URINARY RETENTION 87 0.0026
938 EXPIRED PRODUCT ADMINISTERED 84 0.0025
939 RESPIRATORY FAILURE 184 0.0025
940 PULMONARY EMBOLISM 239 0.0025
941 MULTIPLE SCLEROSIS 120 0.0025
942 GASTRIC DISORDER 86 0.0025
943 BREAST CANCER 232 0.0025
944 ARRHYTHMIA 117 0.0025
945 CONFUSIONAL STATE 398 0.0025
946 ADVERSE EVENT 226 0.0024
947 PROSTATE CANCER 196 0.0024
948 CARDIOVASCULAR DISORDER 61 0.0024
949 CEREBRAL HAEMORRHAGE 86 0.0024
950 VISUAL ACUITY REDUCED 76 0.0023
951 AGITATION 167 0.0023
952 RENAL IMPAIRMENT 191 0.0023
953 RECTAL HAEMORRHAGE 97 0.0023
954 EPILEPSY 69 0.0023
955 UNDERDOSE 155 0.0021
956 HALLUCINATION 158 0.0021
957 ANAEMIA 392 0.0021
958 COGNITIVE DISORDER 94 0.0020
959 DEEP VEIN THROMBOSIS 124 0.0019
960 ABNORMAL BEHAVIOUR 74 0.0019
961 DYSKINESIA 74 0.0018
962 AGGRESSION 91 0.0018
963 SUICIDAL IDEATION 160 0.0017
964 WHITE BLOOD CELL COUNT DECREASED 189 0.0017
965 ACCIDENTAL OVERDOSE 62 0.0017
966 HAEMOGLOBIN DECREASED 170 0.0017
967 WITHDRAWAL SYNDROME 69 0.0016
968 RENAL FAILURE 212 0.0016
969 EMOTIONAL DISTRESS 190 0.0016
970 DRUG DOSE OMISSION 252 0.0015
971 PLATELET COUNT DECREASED 161 0.0015
972 DEATH 1300 0.0015
973 VAGINAL HAEMORRHAGE 65 0.0015
974 CHRONIC KIDNEY DISEASE 111 0.0015
975 INTERSTITIAL LUNG DISEASE 69 0.0014
976 DRUG INTERACTION 222 0.0014
977 SEPTIC SHOCK 59 0.0014
978 GASTROINTESTINAL HAEMORRHAGE 112 0.0013
979 HYPOGLYCAEMIA 64 0.0013
980 CARDIAC ARREST 107 0.0013
981 BLADDER CANCER 65 0.0011
982 BRADYCARDIA 57 0.0011
983 BLOOD CREATININE INCREASED 66 0.0010
984 FOETAL EXPOSURE DURING PREGNANCY 82 0.0010
985 DISEASE PROGRESSION 119 0.0010
986 THROMBOCYTOPENIA 81 0.0007
987 ACUTE KIDNEY INJURY 93 0.0006
988 NEUTROPENIA 80 0.0006
989 OVERDOSE 72 0.0003